Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma — Stella

Home/Glioblastoma/

View on ClinicalTrials.gov

Recruiting

Back to Glioblastoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Spain

Hospital Clínico San Carlos, Madrid

Key details

Phase

Early testing

Sponsor

Hospital San Carlos, Madrid

Collaborators

Asociación de Afectados Por Tumores Cerebrales en España (ASATE)

Enrollment target

~12 participants

Started

March 2024

Primary completion

November 2026

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 75 Years

Last updated May 2024